Emily S. Finn is assistant professor of psychological and brain sciences at Dartmouth College, where she directs the Functional Imaging and Naturalistic Neuroscience (FINN) Lab. Finn has pioneered techniques such as functional connectome fingerprinting and connectome-based predictive modeling for predicting individual behaviors from functional brain connectivity. Her current work is focused on how within- and between-individual variability in brain activity relates to appraisal of ambiguous information under naturalistic conditions such as watching movies or listening to stories.
Emily S. Finn
Assistant professor of psychological and brain sciences
Dartmouth College
From this contributor
To improve big data, we need small-scale human imaging studies
By insisting that every brain-behavior association study include hundreds or even thousands of participants, we risk stifling innovation. Smaller studies are essential to test new scanning paradigms.
To improve big data, we need small-scale human imaging studies
By
Emily S. Finn
15 April 2024 | 7 min read
Explore more from The Transmitter
‘These are not alternative careers’: More neuroscience Ph.D. programs start to facilitate industry internships
The opportunities cater to students interested in careers outside the ivory tower.
‘These are not alternative careers’: More neuroscience Ph.D. programs start to facilitate industry internships
The opportunities cater to students interested in careers outside the ivory tower.
By
Elissa Welle
29 April 2024 | 4 min read
The question of regeneration—an excerpt from ‘Periphery: How Your Nervous System Predicts and Protects Against Disease’
In his recent book, Moses Chao makes the case that the peripheral nervous system can warn of future illnesses.
The question of regeneration—an excerpt from ‘Periphery: How Your Nervous System Predicts and Protects Against Disease’
In his recent book, Moses Chao makes the case that the peripheral nervous system can warn of future illnesses.
By
Moses V. Chao
26 April 2024 | 7 min read
RNA drug corrects calcium signaling in chimeric model of Timothy syndrome
The drug, tested in rats that have human neurons, could enter clinical testing as early as next year, researchers say.
RNA drug corrects calcium signaling in chimeric model of Timothy syndrome
The drug, tested in rats that have human neurons, could enter clinical testing as early as next year, researchers say.
By
Katie Moisse
24 April 2024 | 5 min read